HC Wainwright Rates Conexeu Sciences (CNXU) buy, $20 Price Target

HC Wainwright maintains its buy rating on CNXU with a $20 target price, a 50.60% upside from the current price.

By EarningsIQ Research Desk · Published Jun 22, 2026, 7:01 AM EDT · Updated Jun 22, 2026, 9:06 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

HC Wainwright rated Conexeu Sciences Inc. ($CNXU) "buy" with a $20 price target on June 22, 2026.

Since the rating, $CNXU is down 15.9% after 1 week, down 23.3% after 1 month and down 74.9% to date (from the $12.18 close on Jun 22, 2026).

CNXU Conexeu Sciences Inc.

$3.06 -70.88% past 3 months

Daily close · Oct 16, 2026

Key Points

On June 22, 2026, HC Wainwright reiterated its buy rating on CNXU, setting a price target of $20.
HC Wainwright's $20 price target implies 50.60% upside from Conexeu Sciences Inc.'s ($CNXU) current $13.28 share price.
Shares of CNXU traded at $13.28 on Monday, reflecting market interest in the analyst's target.
The reiterated rating suggests confidence in CNXU's potential, with no insider or peer activity reported.

Get $CNXU trade alerts by text

We text you when insiders, Congress or big funds trade $CNXU. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Conexeu Sciences Inc. alert may contain errors. Disclosures

On June 22, 2026, HC Wainwright reiterated its buy rating for CNXU, setting a price target of $20. This move by analyst Swayampakula Ramakanth underscores the firm's confidence in the company's future prospects.

Analyst rating track record

HC Wainwright & Co. vs. the S&P 500

YTD return +49.04% hypothetical

All-time return +148.12% S&P 500 +29.05%

vs. S&P 500 +119.07% ahead of the index

Hypothetical returns from HC Wainwright & Co.'s disclosed trades, not real profit or advice. How we model this.

Conexeu Sciences Inc. Stock Up 167.7%

Shares of CNXU traded near $13.28 on Monday. The reiterated buy rating and the $20 target indicate a positive outlook from HC Wainwright, suggesting potential upside from current levels.

12-month forecast

$CNXU price target

Conexeu Sciences Inc. daily closes and this analyst's $20 target. Not advice.

Analysts Set New Price Targets

On June 22, 2026, HC Wainwright & Co. initiated coverage on CNXU with a buy rating and a $20 price target. This reflects a strong belief in the company's growth potential and market position.

Bottom Line

HC Wainwright's reiterated buy rating and $20 target for CNXU highlight the firm's continued confidence in the company's growth trajectory. While the analyst's target suggests room for appreciation, investors should consider this as part of a broader investment strategy. As always, it's important to remember that analyst ratings are based on current information and market conditions.